01 March 1999
Results of palliative cytoreduction chemotherapy in patients with advanced non-small cell lung cancer
Anna Słowik-Gabryelska, Agata Kalicka, Władysław LasekMed Sci Monit 1999; 5(2): CR226-232 :: ID: 505091
Abstract
Large number of patients with advanced non-small cell lung cancer (NSCLC), poor prognosis and controversies on the effectiveness of chemotherapy in advanced cases made us analyse our experiences in that matter. The results of paliative chemotherapy in 110 inoperable, and disqualified from radiotherapy NSCLC patients (stage III B, IV) received 2-6 courses of chemotherapy by Le Chevalier (Vincristin, Cyclophosphamide, Lomustine, Cisplatin) or by Rosell (Mitimycin, Ifosfamide, Cisplatin). Control group consisted of 20 persons with advanced NSCLC, who received paliative radiotherapy. The effectiveness of therapy was established on the basis of survival time, number and quality of remissions and performance status. It was established, that effectiveness of treatment depended upon the tolerance of chemotherapy. The more courses of chemotherapy the more remissions, and longer time of survival. The mean time of survival in symptomatically treated patients was 3 months, whereas in chemotherapy group - 11.8 months. In chemotherapy group, the remissions in 82% of patients were obtained, among them 22% complete tumour regressions. Mean time of survival was: 16.1 months in CR, 11.2 months in PR and 5.1 month in patients without answer to treatment. The obtained remissions allowed to resect the tumour in 12% of patients and to apply radiotherapy in about 50%;. In significant part of patients, after chemotherapy the improvement of performance status was seen. The obtained results of treatment are comparable with others in Europe and the USA.
Keywords: palliative chemotherapy, therapy, lung cancer
Editorial
01 April 2024 : Editorial
Editorial: Forty Years of Waiting for Prevention and Cure of HIV Infection – Ongoing Challenges and Hopes for Vaccine Development and Overcoming Antiretroviral Drug ResistanceDOI: 10.12659/MSM.944600
Med Sci Monit 2024; 30:e944600
In Press
06 Mar 2024 : Clinical Research
Comparison of Outcomes between Single-Level and Double-Level Corpectomy in Thoracolumbar Reconstruction: A ...Med Sci Monit In Press; DOI: 10.12659/MSM.943797
21 Mar 2024 : Meta-Analysis
Economic Evaluation of COVID-19 Screening Tests and Surveillance Strategies in Low-Income, Middle-Income, a...Med Sci Monit In Press; DOI: 10.12659/MSM.943863
10 Apr 2024 : Clinical Research
Predicting Acute Cardiovascular Complications in COVID-19: Insights from a Specialized Cardiac Referral Dep...Med Sci Monit In Press; DOI: 10.12659/MSM.942612
06 Mar 2024 : Clinical Research
Enhanced Surgical Outcomes of Popliteal Cyst Excision: A Retrospective Study Comparing Arthroscopic Debride...Med Sci Monit In Press; DOI: 10.12659/MSM.941102
Most Viewed Current Articles
17 Jan 2024 : Review article
Vaccination Guidelines for Pregnant Women: Addressing COVID-19 and the Omicron VariantDOI :10.12659/MSM.942799
Med Sci Monit 2024; 30:e942799
14 Dec 2022 : Clinical Research
Prevalence and Variability of Allergen-Specific Immunoglobulin E in Patients with Elevated Tryptase LevelsDOI :10.12659/MSM.937990
Med Sci Monit 2022; 28:e937990
16 May 2023 : Clinical Research
Electrophysiological Testing for an Auditory Processing Disorder and Reading Performance in 54 School Stude...DOI :10.12659/MSM.940387
Med Sci Monit 2023; 29:e940387
01 Jan 2022 : Editorial
Editorial: Current Status of Oral Antiviral Drug Treatments for SARS-CoV-2 Infection in Non-Hospitalized Pa...DOI :10.12659/MSM.935952
Med Sci Monit 2022; 28:e935952